Ziprasidone

Back to search

Molecule Structure

Scientific Name

Ziprasidone

Description of the Drug

Ziprasidone is an atypical antipsychotic used to manage schizophrenia, bipolar mania, and agitation in patients with schizophrenia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00246

Brand Name(s)

Not Available

Company Owner(s)

Apotex Inc, Cadila Healthcare Ltd, Viatris Specialty Llc, Lupin Pharmaceuticals Inc, Sandoz Inc, Macleods Pharmaceuticals Ltd, Chartwell Rx Sciences Llc, Gland Pharma Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dopamine D2 receptor SINGLE PROTEIN ANTAGONIST CHEMBL217
Serotonin 2a (5-HT2a) receptor SINGLE PROTEIN ANTAGONIST CHEMBL224
Serotonin 2c (5-HT2c) receptor SINGLE PROTEIN ANTAGONIST CHEMBL225

Unichem Links

SureChEMBL SCHEMBL28028
PharmGKB PA451974
Human Metabolome Database HMDB0014391
DrugBank DB00246
PubChem: Thomson Pharma 14782044
PubChem 60854
LINCS LSM-5433
Nikkaji J553.147K
BindingDB 50048803
EPA CompTox Dashboard DTXSID4023753
DrugCentral 2865
Brenda 80130
ChemicalBook CB62131294
Guide to Pharmacology 59
rxnorm ZIPRASIDONE ZIPRASIDONE HYDROCHLORIDE ZIPRASIDONE MESYLATE GEODON
KEGG Ligand C07568
ChEBI 10119
ZINC ZINC000000538550